Red Cell Exchange In Sickle Cell Disease

Slides:



Advertisements
Similar presentations
Administration of Blood and Blood Products PN 3 November 2005.
Advertisements

Plasma Exchange consists of the removal of large volumes of the patient' s plasma and replacing it with exogenous plasma or plasma substitutes Action:
Transfusion ComplicationRisk per UNIT Allergic3:100 Febrile (Leuko-reduced Units) 1:100 TACO1:100 TRALI1:5,000 Sepsis1:5,000 Acute hemolytic1:75,000 HBV1:160,000.
Adverse Effects of Blood Transfusion. Adverse Effects of Blood Transfusion ANY unfavorable consequence is considered an adverse effect of blood transfusion.
End Stage Renal Disease in Children. End stage kidney disease occurs when the kidneys are no longer able to function at a level that is necessary for.
Treatment Options for End Stage Kidney Disease Dr Vipula De Silva.
Blood Components Dosage And Their Administration
Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Acute Chest Syndrome Spring 2013.
Hello. Blood Transfusion What is a Blood Transfusion? Blood transfusion is a medical procedure that needs to be ordered by a physician. It is the introduction.
Tessa Bandhan. Question 1 A 3 year old girl known to have sickle cell disease (Hb SS) presents to the Emergency Room with a 2 day history of weakness.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Single-Donor Platelets: Arguments for Preferential Use Paul M. Ness, MD Transfusion Medicine Division Johns Hopkins Medical Institutions.
بسم الله الرحمن الرحيم. Ahmad Shihada Silmi,Msc, FIBMS Lecturer of Haematology & Immunology Faculty of Science, IUG Autologous Blood BY.
Blood Groups Prof. K. Sivapalan. June 2013Blood grouping2 Blood groups. Transfusion reactions indicated different types of blood among individuals. Surface.
BLOOD TRANSFUSION Begashaw M (MD).
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
+ Dr. Megan Rowley Consultant in Transfusion Medicine Blood Transfusion.
Hepatitis B - Sexually Transmitted Infection - Infects the liver and causes inflammation - About 1/3 people in the world have Hepatitis B - Can lead to.
Transfusions in Sickle Cell Disease Ashley Duckett, MD MUSC June 21, 2012.
DIALYSIS Dr. Frank Edwin.
RESULTS FROM THE 2007 SHOT REPORT. SHOT report 2007 (561 cases)
Blood Product Administration Keith Rischer, RN. Erythrocytes  Function  Normal Life span  Norms Hgb –Women: g/dl –Men: n g/dl HCT –Women:
RESULTS FROM THE 2006 SHOT REPORT. SHOT report 2006.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
Platelet Transfusions Indications, dose and administration
Central Venous Intravenous Catheters The catheter tip lies in the Central Circulatory System close to the right atrium.
Blood and Blood Products. Whole Blood n Contents –RBC’s –WBC’s –Platelets –Plasma –Clotting factors.
Bone Marrow Transplant
Blood Transfusion: It is best to AVOID it Dr. Syed Muhammad Irfan
Blood Transfusions.
Associate professor of Internal Medicine
Nephrology Specialist at New Mansoura General Hospital
K A U H Blood bank Wesaam Al-Sheyyab.
Transfusion Medicine Kristine Krafts, M.D..
TRANSFUSION REACTIONS
BLOOD & BLOOD PRODUCTS.
د.محمد حارث الساعاتي.
Ruth Namazzi, Amos Odiit, Heather Hume, Chandy John, Robert Opoka .
Management of Urinary Tract Infections Renal Block
Blood groups.
Blood Transfusion The reason for a progressive blood sampling strategy by FIS should be considered in the light of the Lahti CC Worlds in 2001 where six.
Management of Urinary Tract Infections Renal Block
Blood transfusion: When to transfuse and risks involved
Crises in Sickle Cell Disease
Intravenous Fluid Administration
BLOOD GROUPS Blood groups are classified according to antigens on the membrane of RBCs called “Agglutinogen”, which are glycoprotein. The plasma may contain.
No:18 Red Cell Contamination In Leukapheresis Product-
Indication of Blood Transfusion in Newborns Dr Bijan Keikhaei Full Professor of Pediatric Hematology and Oncology Research Center for Thalassemia and.
Erythrocytapheresis.
Consultant CPD, November 23rd 2016
BLOOD TRANSFUSION An overview
Transfusion Medicine Kristine Krafts, M.D..
Benefits of autotransfusion
Hemoglobinopathies in Pregnancy
Transfusion in Sickle cell anemia
Molecular medicine ILA
Blood Transfusion Evidence-Based Blood Therapeutics “7 is the NEW 10”
Blood and Blood Product Transfusion Reaction
PRBC Transfusions Medicine Floors Internal Medicine, PGY-3
Sickle cell and pregnancy
Transfusion Medicine Kristine Krafts, M.D..
EFFECT OF DONOR VARIABLES ON YIELD IN SINGLE DONOR PLATELETPHERESIS BY HEMONETICS MCS PLUS ISHAN JOSHI, AMIT SHARMA, RACHNA NARAYAN, SUNITA BUNDAS AND.
K+ and K- red cells; when is it safe to transfuse?
EXTENT OF CHANGES IN PRE AND POSTDONATION DONOR VARIABLES IN SINGLE AND DOUBLE DOSE PLATELETPHERESIS AND ITS IMPLICATIONS ON DONOR SAFETY Dr. R. Sreedevi.
Dr. Kareema Ahmed Hussein
Blood Components Dosage And Their Administration
Iron overload in Sickle Cell disease
HSCT in children with sickle cell Disease
Presentation transcript:

Red Cell Exchange In Sickle Cell Disease Dr. M Joshua Daniel M.D., Consultant Transfusion Medicine MIOT Hospitals Chennai

Definition Red Cell Exchange(RCE): “A therapeutic procedure in which blood of the patient is passed through a medical device(cell separator) which separates RBCs from other components of blood, the patient RBCs are removed and replaced with donor RBCs alone; plus colloid/crystalloid solution

Rationale for transfusion in sickle cell disease Correction of anaemia : Increases O2 carrying capacity Decreases the proportion of Hb S: Reduced sickling/ hemolysis Reduced blood viscosity : if RBC exchange Suppressed erythropoiesis (HbS synthesis)

Indications for RBC exchange in SCD SCD-related complications ASFA indication category Acute RCE Non acute or chronic RCE Acute stoke I Acute chest syndrome, severe II Multiorgan failure III Severe intrahepatic cholestasis Priapism Stoke prophylaxis with prevention of iron overload Vaso- occlusive pain Presurgery Pulmonary hypertension III* End-stage renal disease

Red cell exchange Vs Simple Transfusions SIMPLE TOP UP TRANSFUSIONS Euvolemic procedure Not so limits development of iron overload - Controls HbS and hematocrit Reduces risk associated with increased viscosity Expert man power, technological back up and instruments needed more red cell exposure Comparatively less Comparatively expensive Not expensive

Selection of PRBC PRBCs should be selected less than 2 weeks old (older blood may be given if the presence of red cell antibodies makes the provision of blood difficult) Extended Rh and Kell typed and matched Phenotyped +/- genotyped if needed Prophylactic match if presence of multiple alloantibodies HbS negative, leuko-reduced, not irradiation unless other indication

Instruments used in Automated Red cell exchange

Procedural guidelines These instruments calculate the volume of blood to be removed to achieve the target Hct, the volume of replacement fluid/ volume of packed RBC to achieve the desired post-exchange target Hct level and fraction cell remaining(FCR) ECV is depends on both the type of instrument used. ECV of each instrument is fixed (Generally ECV is 15% of the total blood volume ) PRBC priming is done in children, patients with anaemia and hemodynamic ally unstable patients.

Procedural guidelines Generally 1.5 volume RCE reduces the FCR to 30% of the original. Most of the procedure aim for a post-exchange Hct at 30% and FCR at 30%. In chronic erythrocytapheresis post-exchange Hct is kept under 27% to prevent iron overload Isovolemic hemodilution is performed (RBC depletion with 0.9% NaCl replacement followed by standard RCE).

FCR = % of patient’s pre-procedure RBC remaining at end of exchange

Data required •Sex, height, weight •Patient HCT, average replacement fluid HCT & desired HCT •Fluid balance PRBC : AC ratio 15:1 RCV = TBV x hct Est. TBV M: 70cc/kg F: 65cc/kg Infant: 80cc/kg hild: 70cc/kg 1 .5- Volume exchange reduces the FCR to 30% 2 -Volume exchange reduces the FCR to 15- 20%

Access Options • Peripheral access - 18 gauge dialysis-type steel needles - 18 to 20 gauge angiocaths • AV fistula and grafts • Central venous catheters - Tunneled and Nontunneled • Ports (indicated for power injection) - Single and bilateral - Dual lumen

Potential adverse effects Procedure related : Citrate toxicity (most commonly tingling around lips/fingers) , headache, light-headedness, fainting, BP changes, vagal symptoms, nausea, vomiting, chills, fever, malaise, weakness Thrombocytopenia: Vascular access related: Thrombosis Bleeding, infection, pain Transfusion related: Usual risks associated with labile products including potentially fatal ones like acute hemolytic reaction, TRALI, major allergic reaction, bacterial contamination Most common remain fever and minor allergic reaction

Potential adverse effects Cont.... Alloimmunization : Risk of delayed hemolytic transfusion reaction ; Risk of hyperhemolysis (of particular concern in SCD population and due to very high cumulative exposure to foreign antigens ) Iron overload: possible if cumulative gain of RBC Transmission of infectious agents: extremely low risk currently but new pathogen can appear Anti-hypertensive medications and diuretics may need to be withheld

Conclusion Automated red cell exchange offers many advantages over simple transfusion or manual partial exchange in sickle cell disease patients It is very effective to treat/prevent certain complications of sickle cell disease However, patients are exposed to multiple RBC units when compared to simple transfusions, with the risks that this holds The growth in red cell exchange in recent years is putting an increasing burden to recruit and phenotype donors,

RCE Our experience @MIOT More than 100 RCE since 2013: Optia- Terumo BCT Most commonly for AVN – Hip for Hip replacement Average pre RCE HBS- 73 to 85% Around 30% presented with HBS and anaemia 98% of the cases the RCF was brought to less than 30% in single procedure Most common complications- citrate toxicity, alloimmunisation, catheter related, utricaria. One patient presented with Delayed Hyper-hemolysis syndrome

Take home message The choice of transfusion method, simple or exchange, should be based on clinical judgement of individual cases, taking in account the indication for transfusion and the need to avoid hyperviscosity and minimise alloimmunisation, maintenance of iron balance and venous access issues. Centres not affordable to fully automated exchanges can adopt and practice isovolumic manual exchange

Normal RBC transfusions are recommended for anaemia when haemoglobin is <9g/dL / patients / uncomplicated pain crises.  RCE, however, should considered to treat / prevent complications in patients with SCD, Acute stroke management and prophylaxis Severe acute chest syndrome, Severe sickle cell hepatopathy, Multiorgan failure Iron overload Hyperviscosity (latest AABB recommendations)

Question-1 Which among the following is category-1 indication of Red cell exchange in SCD? Acute Stroke Acute severe chest syndrome Multi organ failure Priapism

Question-2 Simple top up transfusions are recommended when the base line haemoglobin concentration is less than……..? (According to latest AABB recommendations) 8 gms% 9 gms% 10gms% 7 gms%